Newlink Genetics reported $0 in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Agenus AGEN:US $ 0M 12.82M
Bristol Myers Squibb BMY:US $ 37450M 2155M
Capricor Therapeutics CAPR:US $ 3.38M 0M
Celldex Therapeutics CLDX:US $ 0M 0M
Eli Lilly And LLY:US $ 15152.9M 193.5M
Idera Pharmaceuticals IDRA:US $ 0M 0M
Intrexon XON:US $ 201.11M 18.36M
Merk MRK:US $ 30586M 104M
Nektar Therapeutics NKTR:US $ 0M 0M
Newlink Genetics NLNK:US $ 0M 0M
Pfizer PFE:US $ 35656M 539M
Prothena PRTA:US 0 0
Sarepta Therapeutics SRPT:US $ 1098.85M 1.97M
Vascular Biogenics VBLT:US 0 0
YTE INCY:US $ 31.38M 0.25M